{'output': [['Biogen Inc.', 'COMP', 'Announce', 'fourth quarter and year-end 2017 financial results', 'ECON_INDICATOR'], ['Biogen Inc.', 'COMP', 'Host', 'live webcast', 'EVENT'], ['Biogen Inc.', 'COMP', 'Operate_In', 'Massachusetts', 'GPE'], ['Biogen Inc.', 'COMP', 'Produce', 'innovative therapies', 'PRODUCT'], ['Biogen Inc.', 'COMP', 'Control', 'leading portfolio of medicines to treat multiple sclerosis', 'PRODUCT'], ['Biogen Inc.', 'COMP', 'Introduce', 'first and only approved treatment for spinal muscular atrophy', 'PRODUCT'], ['Biogen Inc.', 'COMP', 'Relate_To', 'neurology research for conditions including Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis', 'CONCEPT'], ['Biogen Inc.', 'COMP', 'Manufacture and commercializes', 'biosimilars of advanced biologics', 'PRODUCT']]}